175 related articles for article (PubMed ID: 11899204)
1. Expression status of E-cadherin and alpha-, beta-, and gamma-catenins in thymoma.
Yoshino I; Kase S; Yano T; Sugio K; Sugimachi K
Ann Thorac Surg; 2002 Mar; 73(3):933-7. PubMed ID: 11899204
[TBL] [Abstract][Full Text] [Related]
2. Expression of e-cadherin and catenins in early gastric cancer.
Joo YE; Rew JS; Choi SK; Bom HS; Park CS; Kim SJ
J Clin Gastroenterol; 2002 Jul; 35(1):35-42. PubMed ID: 12080224
[TBL] [Abstract][Full Text] [Related]
3. Expression of E-cadherin and alpha- and beta-catenins in thymoma.
Pan CC; Ho DM; Chen WY; Chiang H; Fahn HJ; Wang LS
J Pathol; 1998 Feb; 184(2):207-11. PubMed ID: 9602713
[TBL] [Abstract][Full Text] [Related]
4. Expression of E-cadherin and alpha-, beta-, gamma-catenin proteins in endometrial carcinoma.
Kim YT; Choi EK; Kim JW; Kim DK; Kim SH; Yang WI
Yonsei Med J; 2002 Dec; 43(6):701-11. PubMed ID: 12497652
[TBL] [Abstract][Full Text] [Related]
5. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.
Ohene-Abuakwa Y; Noda M; Perenyi M; Kobayashi N; Kashima K; Hattori T; Pignatelli M
J Pathol; 2000 Dec; 192(4):433-9. PubMed ID: 11113859
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.
Endo K; Ueda T; Ueyama J; Ohta T; Terada T
Hum Pathol; 2000 May; 31(5):558-65. PubMed ID: 10836294
[TBL] [Abstract][Full Text] [Related]
7. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity.
Bagutti C; Speight PM; Watt FM
J Pathol; 1998 Sep; 186(1):8-16. PubMed ID: 9875134
[TBL] [Abstract][Full Text] [Related]
8. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.
Gonzalez MA; Pinder SE; Wencyk PM; Bell JA; Elston CW; Nicholson RI; Robertson JF; Blamey RW; Ellis IO
J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116
[TBL] [Abstract][Full Text] [Related]
9. Expression of E-cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120) in colorectal polyps.
Valizadeh A; Karayiannakis AJ; el-Hariry I; Kmiot W; Pignatelli M
Am J Pathol; 1997 Jun; 150(6):1977-84. PubMed ID: 9176391
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the clinicopathological significance of E-cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma.
Chow V; Yuen AP; Lam KY; Tsao GS; Ho WK; Wei WI
J Cancer Res Clin Oncol; 2001 Jan; 127(1):59-63. PubMed ID: 11206273
[TBL] [Abstract][Full Text] [Related]
11. Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers.
Joo YE; Rew JS; Kim HS; Choi SH; Park CS; Kim SJ
Digestion; 2001; 64(2):111-9. PubMed ID: 11684825
[TBL] [Abstract][Full Text] [Related]
12. Role of E-cadherin, alpha-, beta-, and gamma-catenins, and p120 (cell adhesion molecules) in prolactinoma behavior.
Qian ZR; Li CC; Yamasaki H; Mizusawa N; Yoshimoto K; Yamada S; Tashiro T; Horiguchi H; Wakatsuki S; Hirokawa M; Sano T
Mod Pathol; 2002 Dec; 15(12):1357-65. PubMed ID: 12481018
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors.
Shimazui T; Schalken JA; Giroldi LA; Jansen CF; Akaza H; Koiso K; Debruyne FM; Bringuier PP
Cancer Res; 1996 Sep; 56(18):4154-8. PubMed ID: 8797585
[TBL] [Abstract][Full Text] [Related]
14. Expression of E-cadherin and alpha-,beta- and gamma-catenins in human bladder carcinomas: are they good prognostic factors?
Mialhe A; Louis J; Montlevier S; Peoch M; Pasquier D; Bosson JL; Rambeaud JJ; Seigneurin D
Invasion Metastasis; 1997; 17(3):124-37. PubMed ID: 9702939
[TBL] [Abstract][Full Text] [Related]
15. The significance of E-cadherin and alpha-, beta-, and gamma-catenin expression in surgically treated non-small cell lung cancers of 3 cm or less in size.
Lee YC; Wu CT; Chen CS; Hsu HH; Chang YL
J Thorac Cardiovasc Surg; 2002 Mar; 123(3):502-7. PubMed ID: 11882822
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
17. Expression of cadherins and their undercoat proteins (alpha-, beta-, and gamma-catenins and p120) and accumulation of beta-catenin with no gene mutations in synovial sarcoma.
Sato H; Hasegawa T; Kanai Y; Tsutsumi Y; Osamura Y; Abe Y; Sakai H; Hirohashi S
Virchows Arch; 2001 Jan; 438(1):23-30. PubMed ID: 11213832
[TBL] [Abstract][Full Text] [Related]
18. The expression of E-cadherin and catenins in sporadic colorectal carcinoma.
El-Bahrawy MA; Poulsom R; Jeffery R; Talbot I; Alison MR
Hum Pathol; 2001 Nov; 32(11):1216-24. PubMed ID: 11727261
[TBL] [Abstract][Full Text] [Related]
19. The potential role of abnormal E-cadherin and alpha-, beta- and gamma-catenin immunoreactivity in the determination of the biological behaviour of keratoacanthoma.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
Br J Dermatol; 2001 Oct; 145(4):582-9. PubMed ID: 11703284
[TBL] [Abstract][Full Text] [Related]
20. Biological relevance of E-cadherin-catenin complex proteins in primary epithelial ovarian tumours.
Faleiro-Rodrigues C; Macedo-Pinto IM; Maia SS; Vieira RH; Lopes CS
Gynecol Obstet Invest; 2005; 60(2):75-83. PubMed ID: 15785075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
